Skip to Content

Notice

Peripheral and Central Nervous System Drugs Advisory Committee; Cancellation

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is cancelling the meeting of the Peripheral and Central Nervous System Drugs Advisory Committee scheduled for May 16, 2003. This meeting was announced in the Federal Register of April 14, 2003 (68 FR 17958).

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Karen M. Templeton-Somers, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area) code 12543, or e-mail: SomersK@cder.fda.gov.

End Further Info Start Signature
Start Printed Page 20159

Dated: April 18, 2003.

Lester M. Crawford,

Deputy Commissioner.

End Signature End Preamble

[FR Doc. 03-10150 Filed 4-23-03; 8:45 am]

BILLING CODE 4160-01-S